Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Emend (Fosaprepitant Dimeglumine) for Injection
Company:  Merck & Co., Inc.
Application No.:  022023s000
Approval Date: 1/25/2008



Date created: April 21, 2009

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.